Rigel Pharmaceuticals Inc RIGL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:19 AM EDT
2.07quote price arrow down-0.05 (-2.36%)
Volume
299,378
52 week range
1.80 - 4.62
Loading...
  • Open2.15
  • Day High2.18
  • Day Low2.06
  • Prev Close2.12
  • 52 Week High4.62
  • 52 Week High Date06/29/21
  • 52 Week Low1.80
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap356.14M
  • Shares Out172.05M
  • 10 Day Average Volume2.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change-20.86

KEY STATS

  • Open2.15
  • Day High2.18
  • Day Low2.06
  • Prev Close2.12
  • 52 Week High4.62
  • 52 Week High Date06/29/21
  • 52 Week Low1.80
  • 52 Week Low Date05/12/22
  • Market Cap356.14M
  • Shares Out172.05M
  • 10 Day Average Volume2.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change-20.86

RATIOS/PROFITABILITY

  • EPS (TTM)-0.50
  • P/E (TTM)-4.17
  • Fwd P/E (NTM)-4.02
  • EBITDA (TTM)-75.831M
  • ROE (TTM)-199.44%
  • Revenue (TTM)84.95M
  • Gross Margin (TTM)98.95%
  • Net Margin (TTM)-99.89%
  • Debt To Equity (MRQ)439.06%

EVENTS

  • Earnings Date08/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rigel Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Rigel Pharmaceuticals, Inc. is a biotechnology company. The Company is engaged in discovering, developing and providing small molecule drugs that improve the lives of patients with hematologic disorders, cancer and rare immune diseases. The Company's research focuses on signaling pathways that are critical to disease mechanisms. The Company's product, TAVALISSE (fostamatinib disodium hexahydrate) tablets, the spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult...
Gary Lyons
Independent Chairman of the Board
Raul Rodriguez
President, Chief Executive Officer, Director
Dean Schorno CPA
Chief Financial Officer, Executive Vice President
Dolly Vance
Executive Vice President, Corporate Affairs, General Counsel and Corporate Secretary
Wolfgang Dummer M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Address
1180 Veterans Blvd
South San Francisco, CA
94080-1985
United States

Top Peers

SYMBOLLASTCHG%CHG
ADMA
ADMA Biologics Inc
2.02-0.04-1.71%
HRTX
Heron Therapeutics Inc
3.50-0.07-2.10%
MGNX
MacroGenics Inc
3.89-0.01-0.26%
PSNL
Personalis Inc
4.26-0.12-2.74%
CCCC
C4 Therapeutics Inc
6.60-0.01-0.15%